Could a spinal implant ease chemo pain? new trial aims to find out

NCT ID NCT07579611

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a spinal cord stimulator can reduce chronic nerve pain caused by chemotherapy. 68 adults with pain lasting over a year will have the device implanted and then randomly receive either active or sham stimulation. The goal is to see if active stimulation provides better pain relief than placebo, and to measure effects on quality of life, sleep, and mood.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
spinal cord stimulation device
What this could lead to
If it works, this could offer a new option for people with long-term nerve pain after chemotherapy, when standard painkillers have failed.
What could go wrong
This is a small, early-stage crossover trial with only 68 participants. The sham phase means patients may not benefit during that period, and device implantation carries surgical risks like infection or lead movement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER RELATED PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hopital de la Timone

    Marseille, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.